Novavax (NVAX) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.74 +2.96%
Revenue Growth %: -78.2%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
CRMT, More
Revenue Growth %: -78.2%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Six Flags names Mark Pauls as chief operating officer
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
